Medtronic Continues to Lead the Way! Breaks Ground on New Innovation Center for 1,000 Plus Employees in Lafayette, Colorado

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the groundbreaking of a new campus in Lafayette, Colorado. Scheduled to begin in June 2021, the new campus will unite employees from the Boulder and Louisville facilities onto one campus. Medtronic’s manufacturing operations currently at the Boulder and Louisville campuses will remain there.

“Medtronic medical technology developed and manufactured in Colorado transforms patient care globally, and we anticipate continued innovation at our new Lafayette campus,” said Geoff Martha, Medtronic chairman and chief executive officer. “We look forward to coming together at a single campus to bolster our presence in Colorado and position Medtronic for growth. In addition, we are investing in this innovation center and new campus to attract and retain technology talent in this tech-rich region of Colorado.”

“We’re thrilled with Medtronic’s investment in Colorado,” said Governor Jared Polis. “This new campus will allow for good jobs, innovation, and employee wellness, all of which are critical to powering the Colorado Comeback.”

Developed in partnership with Ryan Companies US, Inc. — a national developer, designer, builder, and property manager offering full-service commercial real estate solutions — the Lafayette campus will span 42 acres with 23 developable acres. Anticipated to be complete with employees moving in during the second half of 2022, the plan includes 400,000 square feet in two five-story connected buildings, which will host 1,100 employees. Campus employee benefits include a full-service cafeteria with indoor and outdoor seating, fitness center, outdoor open spaces, areas for team activities, indoor and outdoor bicycle parking, a ¾ mile recreation loop, and access to trails and public transportation.

“With nearly 11,000 scientists and engineers worldwide and approximately 600 employees in R&D roles in Colorado, Medtronic has over 49,000 patents in our portfolio to date and is running more than 350 clinical trials. Once settled at our new Colorado campus, we will continue to collaborate with each other, our customers, and our partners to develop and produce innovative technologies backed by science,” said Martha.

Medtronic is committed to providing a sustainable, comfortable, healthy, and productive workplace that complements the surrounding natural environment. The building designs feature reduced water and irrigation use, solar parking canopies, electric vehicle charging stations, pollinator gardens, energy efficient building systems, occupancy sensors, and LED lighting. To help ensure employee safety, the site will be equipped with state-of-the-art ventilation, filtration, and air distribution systems capable of 100 percent outside air economizing to bring in outdoor air, and fully automated and programmable air handles.

SourceMedtronic

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version